Table 1.
Characteristics of the patients infected by Mycobacterium leprae, according to their clinical forms and laboratory data
| Patients | Sex | Year/ origin | Age (years) | Clinical form | Leprosy reaction | BI | Mitsuda test (mm) | Histopathology |
|---|---|---|---|---|---|---|---|---|
| P1 | F | 96, UDI | 45 | BB | Type 1 (RR) | 0 | 0 | BB Granuloma, AARB 2+ |
| P2 | M | 96, UDI | 45 | LL | Type 2 (ENL) | 4·5 | 0 | LL Infiltrate, AARB 5+ |
| P3 | M | 97, UDI | 35 | LL | – | 5·25 | 0 | LL Infiltrate, AARB 5+ |
| P4 | F | 97, UDI | 44 | LL | – | 2·0 | 0 | LL Infiltrate, AARB 4+ |
| P5 | F | 97, UDI | 35 | LL | – | 3·0 | 0 | LL Infiltrate, AARB 4+ |
| P6 | F | 97, UDI | 61 | BB | Type 1 (RR) | 0 | 2 | BB Granuloma, AARB 1+ |
| P7 | F | 97, UDI | 25 | LL | – | 5·5 | 0 | LL Infiltrate, AARB 6+ |
| P8 | M | 97, UDI | 67 | BT | – | 0 | 6 | BT Granuloma, AARB− |
| P9 | F | 97, RP | 46 | BL | Type 2 (ENL) | 3·0 | 0 | BL Infiltrate, AARB 4+ |
| P10 | M | 97, RP | 68 | TT | – | 0 | 5 | TT Granuloma, AARB− |
| P11 | M | 97, RP | 46 | BT | – | 0 | 1 | BT Granuloma, AARB 1+ |
| P12 | M | 97, RP | 54 | LL | Type 2 (ENL) | 3·75 | 0 | LL Infiltrate, AARB 5+ |
| P13 | M | 97, RP | 25 | TT | – | 0 | 7 | TT Granuloma, AARB− |
| P14 | F | 97, RP | 45 | BL | Type 2 (ENL) | 3·0 | 0 | LL Infiltrate, AARB 3+ |
| P15 | M | 97, RP | 22 | BL | Type 2 (ENL) | 3·0 | 0 | BL Infiltrate, AARB 3+ |
| P16 | M | 98, RP | 54 | TT | – | 0 | 8 | TT Granuloma, AARB− |
| P17 | F | 98, RP | 57 | BL | – | 1·5 | 0 | BL Infiltrate, AARB 4+ |
| P18 | M | 98, RP | 41 | BT | Type 1 (RR) | 0 | 5 | BT Granuloma, AARB− |
| P19 | M | 99, RP | 36 | BT | – | 0 | 5 | BT Granuloma, AARB 1+ |
RR, Reversal reaction; ENL, erythema nodosum leprosum; BI, bacilloscopic index; AARB, alcohol-acid-resistant bacilli; UDI, Uberlândia – MG; RP, Ribeirão Preto – SP, Brazil.